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Abstract
Background: Outcome measures for patients hospitalized with pneumonia may complement process measures in
characterizing quality of care. We sought to develop and validate a hierarchical regression model using Medicare claims
data that produces hospital-level, risk-standardized 30-day mortality rates useful for public reporting for patients
hospitalized with pneumonia.
Methodology/Principal Findings: Retrospective study of fee-for-service Medicare beneficiaries age 66 years and older with
a principal discharge diagnosis of pneumonia. Candidate risk-adjustment variables included patient demographics,
administrative diagnosis codes from the index hospitalization, and all inpatient and outpatient encounters from the year
before admission. The model derivation cohort included 224,608 pneumonia cases admitted to 4,664 hospitals in 2000, and
validation cohorts included cases from each of years 1998–2003. We compared model-derived state-level standardized
mortality estimates with medical record-derived state-level standardized mortality estimates using data from the Medicare
National Pneumonia Project on 50,858 patients hospitalized from 1998–2001. The final model included 31 variables and had
an area under the Receiver Operating Characteristic curve of 0.72. In each administrative claims validation cohort, model fit
was similar to the derivation cohort. The distribution of standardized mortality rates among hospitals ranged from 13.0% to
23.7%, with 25
th,5 0
th, and 75
th percentiles of 16.5%, 17.4%, and 18.3%, respectively. Comparing model-derived risk-
standardized state mortality rates with medical record-derived estimates, the correlation coefficient was 0.86 (Standard
Error=0.032).
Conclusions/Significance: An administrative claims-based model for profiling hospitals for pneumonia mortality performs
consistently over several years and produces hospital estimates close to those using a medical record model.
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Introduction
Pneumonia, the second most common cause of hospitalization of
the elderly, accounts for approximately 770,000 admissions
annually among patients 65 years of age or older in the United
States [1,2]. Hospitalization rates for pneumonia have increased by
20%from 1988–1990 to 2000–2002 forpatients aged 65 to 84 years
[2]. The combined reporting category of pneumonia and influenza
remains the fifth leading cause of death in this age group [3].
Care of patients with pneumonia has been the target of quality
measurement and reporting initiatives [4,5]. Two of the largest
initiatives focused on the quality of pneumonia care are the
Centers for Medicare & Medicaid Service’s (CMS) National
Pneumonia Project and The Joint Commission ORYXH initiatives
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e17401[4,5]. Both are characterized by routine measurement of
performance on process measures of care given at the time of
admission (antibiotic timing and selection, oxygenation assess-
ment, and blood cultures) and before discharge (smoking cessation
counseling, and provision of influenza and pneumococcal
polysaccharide vaccines).
Although measuring processes of care for pneumonia has
accelerated the pace of quality improvement [6–8], there is an
ongoing need to develop new measures of pneumonia quality that
focus on patient outcomes, care transitions, and efficiency of care.
Process measures can provide important information about the
quality of care and guide improvement efforts; however, these
measures necessarily focus on a small spectrum of the overall care
provided to hospitalized patients. Outcome measures that reflect
the patient’s subsequent health status, such as satisfaction with
care, functional status, morbidity, mortality, or parameters such as
length of stay or costs of care, are generally regarded as the
indicators that are most meaningful to patients and/or payers
[6,9,10]. CMS has begun focusing resources of the development of
new measures of patient outcomes, in part because of provisions in
Section 5001 of the Deficit Reduction Act (DRA) of 2005 (Public
Law 109–171) that require the Secretary of Health and Human
Services to begin reporting hospital quality measures of process,
structure, outcome, patients’ perspective on care, efficiency, and
costs of care.
This report describes the 30-day risk-standardized mortality
model based on Medicare claims for patients discharged with a
diagnosis of pneumonia developed for public reporting. This effort
is an extension of an ongoing initiative by CMS to develop
outcomes measures for common conditions that are based on
available national data. In the first phase of the CMS initiative,
risk-standardized measures of 30-day mortality for acute myocar-
dial infarction [11] and heart failure [12] were developed using
administrative data and were demonstrated to have properties
suitable for public reporting [13]. CMS reports annually the
measure results for all 3 conditions for the nation’s acute care
hospitals.
Methods
Patient Sample
The target population was patients aged 66 years and older who
were hospitalized in non-governmental, acute care hospitals with a
discharge diagnosis of pneumonia and who were enrolled in fee-
for-service Medicare coverage in the 12 months before and
including the time of their index hospitalization. A patient was
excluded if there was incomplete administrative data for the period
12 months before the index admission date; if the patient was not
enrolled in Medicare for the entire year before admission or if the
patient was enrolled in a managed care (Medicare+Choice) plan
during the previous year; if pneumonia was listed as a secondary
diagnosis (to eliminate pneumonia resulting from complications of
hospitalization); and if the patient was discharged alive and not
against medical advice within the first day of admission because of
concerns about the accuracy of the pneumonia diagnosis. For
patients with more than 1 hospitalization, only 1 admission was
randomly selected. We did this to ensure the independence of the
observations. Thus our sample included all patients having a
pneumonia diagnosis during a particular year.
For patients who were transferred from one institution to
another, we linked the hospitalizations into an episode of care. The
hospitalization was considered to have begun on admission to the
initial hospital. A patient needed to be admitted as an inpatient at
both the transferring and receiving hospital, and was required to
have a pneumonia discharge diagnosis at both hospitals. To
exclude admissions of patients discharged and subsequently
readmitted, transfers must have occurred within 1 day or less,
counting from the discharge date of the initial hospitalization. For
the purposes of risk-adjustment, comorbid (‘‘pre-existing’’) condi-
tions were identified from the initial (index) admission only to
avoid designating index admission-related complications as pre-
existing conditions in the receiving hospital. Comorbid conditions
that may have represented complications of the index admission
were not included in the risk-adjustment model. For the purposes
of calculation of risk-stratified mortality rates, the initial hospital
was designated as the responsible institution for the patient’s
episode of care.
Derivation and Validation Cohorts
We created the derivation cohort using the 2000 Medicare
Provider Analysis and Review (MEDPAR) files, by selecting
hospitalizations for pneumonia (International Classification of Diseases,
9
th Revision, Clinical Modification (ICD-9-CM) codes 481, 482.XX,
483.X, 485, 486, and 487.0. Cases were stratified by hospital and
then 50% of the patients from each hospital were randomly
sampled in order to include cases from all hospitals where possible
(Figure 1).
We evaluated the performance of the administrative claims
model in validation cohorts using the other half of the 2000
MEDPAR data, and all claims data for each of years 1998, 1999,
2001, 2002, and 2003 (Figure 1). For each year we developed the
study sample using the same approach as that employed for the
derivation cohort.
To compare the results of the statistical models developed from
Medicare claims with those from models using data collected from
medical records, we identified a sample of patients for whom we
had both administrative claims and detailed chart abstracted
medical record data. The medical record data were obtained from
the CMS National Pneumonia Project, in which patient charts
from hospitalizations for pneumonia are routinely abstracted [14].
Details of chart selection and abstraction in the National
Pneumonia Project have been previously published [14]. Medical
records for 2 large pneumonia cohorts of up to 850 randomly
selected patients per state during each of 2 time periods between
July 1998 through March 1999 or July 2000 and June 2001 were
available for this study. Because the sample of abstracted medical
records was not sufficient for hospital-level comparisons of the 2
models, comparisons of model performance were made at the state
level.
Outcome
The patient outcome was all-cause 30-day mortality from the
time of admission. We obtained mortality information from the
Medicare enrollment files by linking unique patient identifiers.
Because our focus was on the hospital, our primary outcome was
hospital-specific, risk-standardized mortality rates (RSMRs),
defined as the hospital-predicted rate divided by the hospital-
expected rate and then multiplied by the observed national rate.
Model Derivation: Patient Predictors of Mortality
We used the ICD-9-CM codes to identify candidate variables for
the Medicare claims model. The MEDPAR claims have data on
each hospitalization for fee-for-service Medicare enrollees and
include demographic information, principal and secondary
diagnosis codes, and procedure codes. Diagnosis codes for
comorbidities were also collected from physician and hospital
outpatient files. Because there are more than 15,000 ICD-9-CM
codes, we used the Hierarchical Condition Categories (HCC) to
Claims Model for Mortality
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This system, which includes 189 categories, was developed by
physician and statistical consultants under a contract to CMS and
is publicly available. The HCC candidate variables considered for
this model were derived from the secondary diagnosis and
procedure codes from the index hospitalization and from the
principal and secondary diagnosis codes from hospitalizations,
institutional outpatient visits, and physician encounters within the
12 months before the index hospitalization. We combined
categories of HCC variables based on clinical judgment and
bivariate associations, and eliminated candidate variables with a
,1% frequency. Additional candidate variables included demo-
graphic (age, sex) and procedural factors (history of bypass surgery
or percutaneous coronary intervention in the past year). A total of
138 HCC variables met the above criteria and were included in
the initial model. The final number of variables in the model
included 2 demographic variables (age and sex), 21 comorbidity
variables, and 8 pneumonia-specific variables.
Model Development. We estimated hierarchical generalized
linear models (HGLMs) [16–18]. We modeled the log-odds of
mortality within 30-days of admission as a function of patient
demographic and clinical characteristics, and a random hospital-
specific effect. This strategy accounts for within-hospital
correlation of the observed outcomes, and reflects the
assumption that underlying differences in quality among the
hospitals being evaluated lead to systematic differences in
outcomes.
We selected the covariates for the final claims model using a
backwards elimination procedure through the generalized linear
model (GLM) with a logit link function approach. Because of the
large number of patient observations, we chose an exit criterion for
a variable with a p.0.01. For each model, we calculated several
indices for assessing model performance [19] at the patient level:
the area under the Receiver Operating Characteristic (ROC)
curve, explained variation as measured by the generalized R
2
statistic, over-fitting indices (intercepts and slopes), and the
observed outcomes in strata defined by the lowest and highest
deciles based on predictive probabilities. Models with ROC areas
close to 1, high R
2, over-fitting intercepts near 0 and intercepts
close to 1, and a large range of observed mortality between the 2
deciles are desirable [19]. We further assessed model fit through
examination of Pearson residuals. After identifying covariates for
the model, we re-estimated the regression coefficients of the
covariates identified from our backward elimination strategy using
HGLM.
Model Validation
Medicare Claims Data. We validated the model by
comparing its performance in the derivation set with various
validation cohorts, as described above. In each validation dataset
we recalibrated the model, so that we used the same variables but
fit the model to the data for each specific cohort.
Medical Record Data. We compared the results from the
claims model with those from a model based on information
abstracted from the medical record. Risk factors identified by the
Pneumonia Patient Outcomes Research Team (PORT) were used
as independent variables in the medical record model [20].
Because some covariates could be missing for patients based on
chart review, we added a category for missing values where
applicable. For each abstracted variable with missing values, we
Figure 1. Development of the derivation and validation cohorts for the pneumonia mortality models. The administrative derivation
cohort included a stratified random sample of half of the eligible pneumonia discharges for calendar year 2000. Subsequent administrative validation
cohorts included the other half of eligible discharges from 2000, and all eligible discharges for calendar years 1998, 1999, and 2001–2003. The chart
model derivation cohort included 50,858 eligible patients with abstracted medical record data. An additional administrative validation cohort using
the claims of patients in the chart model derivation cohort was created to compare state-specific standardized mortality rates generated by the 2
models.
doi:10.1371/journal.pone.0017401.g001
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include in the model any variable with a high missing value rate
(greater than 10%). We then created a dummy variable to
represent the missing value corresponding to the abstracted
variable, and used the dummy variable together with the
abstracted variable in the model. This method of modeling
missing data assumes that the data are missing at random and
permits inclusion of all available cases, although it is not as efficient
as multiple imputation procedures. We computed measures of
model fit and discrimination for the medical record model similar
to those computed for the claims-based models.
RSMRs
We calculated the RSMR for each hospital using the estimated
hospital-specific parameters from the respective hierarchical
models. These rates are obtained as the ratio of predicted to
expected mortality (similar to the observed/expected ratio),
multiplied by the national unadjusted rate [21]. The ratio is
predicted mortality in each hospital, given its patient mix and
hospital-specific effect, divided by the expected mortality in that
hospital given the same patient mix and the national average [21].
The predicted hospital outcome is the number of expected
mortalities in the ‘‘specific’’ hospital. Operationally, we estimated
all the model parameters by regressing the outcomes on the
predictors for the entire sample. We then multiplied the estimated
regression coefficients by the patient characteristics observed in
each hospital, added the hospital-specific estimated intercept,
transformed to the probability scale, and then summed over all
patients in the hospital. The expected outcome for each hospital is
the number of 30-day deaths expected in the hospital given the
observed case-mix. We then multiplied the, estimated regression
coefficients by the patient characteristics observed in each hospital,
added the national intercept, transformed to the probability scale,
and then summed overall all patients in the hospital. This strategy
is a form of indirect standardization. The higher a hospital’s
predicted 30-day mortality rate, relative to expected mortality for
the hospital’s particular case mix of patients, the higher its adjusted
mortality rate will be.
To assess the validity of the administrative data model, we
calculated state-specific RSMR using the procedures described
above and compared these rates with state-specific RSMRs
obtained from the medical record model. Because the selection of
cases for chart abstraction as a part of the National Pneumonia
Project [14] was done at the state level, the number of patients with
available medical record data from each hospital was relatively
small. We thus used 2 approaches to examine the relationship
between the RSMRs obtained from administrative data and
medical recorddata. First, we estimateda linearregressionequation
describing the linear association between the 2 rates, weightingeach
state by the number of hospitalizations, and calculated the intercept
and the slope of this equation. A slope close to 1 and an intercept
close to 0 would indicate a strong linear relationship. Second, for
eachstatewe calculated thedifference between the RSMR based on
the claims data and the medical record data, and then summarized
the distribution of these differences among the hospitals using the
average, median, and maximum difference. Differences close to 0
would support agreement between the claims-based and medical
record-based approaches.
Stability of the Model over Time
We compared the performance of the claims model over time in
various validation cohorts, calculating similar model fit indices as
those used in the derivation and validation samples. To assess
whether we included too many risk factors in our final model, we
calculated indices that quantify overfitting. Specifically, we used
the coefficients estimated from the derivation model to predict the
log-odds of mortality in the validation cohorts. This was
accomplished by multiplying the observed risk factors in each
validation cohort and summing over the covariates for a subject to
obtain a mortality score. Using these scores for each subject, we
then estimated a logistic regression model in which the outcome
was observed mortality and the single covariate was the risk score.
The intercept and slope obtained from this model are referred to
as overfitting indices. If there is overfitting, we would expect the
slopes to be different from 1 and the intercepts to be different from
0. We repeated this process for each validation dataset, each time
calculating a risk score using the regression estimates from our
derivation model.
After computing the overfitting statistics, in each validation
dataset, we recalibrated the model so that we used the same
variables but fit the model to the data for each specific cohort. For
each model, we calculated the same indices for assessing model
performance [19] as in the derivation model.
All analyses were conducted using SAS version 8.02 (SAS
Institute Inc., Cary, NC). Models were fitted separately to each
year of data. The hierarchical models were estimated with the use
of the GLIMMIX macro in SAS. Ethics committee approval and
written consent from patients for the analysis were not required.
This analysis was performed under a CMS-directed contract with
the Colorado Foundation for Medical Care (CFMC), the
Colorado Quality Improvement Organization. As such, CFMC
functions as a health oversight agency; institutional ethics
committee approval and written consent for release of information
is therefore not required.
Results
Patient Characteristics and Administrative Model
The patient study samples used to create the derivation and
validation cohorts for the administrative claims models are
summarized in Table S1 and Figure 1. The 2000 MEDPAR
dataset included 683,280 pneumonia discharges from 4,684
hospitals. The model derivation cohort consisted of approximately
half of the eligible patients discharged in 2000 resulting in 224,608
cases randomly selected from 4,644 hospitals. The mean age of the
cohort was 80.268 years. The cohort included 55.8% women and
12.0% nonwhite patients. The overall unadjusted 30-day mortality
rate for the derivation cohort was 15.1%. The median annual
number of Medicare pneumonia hospitalizations from the deriva-
tion sample hospitals was 37, ranging from 1 to 396, and across
these hospitals (25
th and 75
th percentiles, 18 and 67, respectively).
On the basis of clinical review of candidate variables, bivariate
analysis, and the stepwise GLM procedure, we identified 31
variables (2 demographic and 29 clinical) for the final model. The
estimated parameters from the HGLM are summarized in Table
S2. No variable has a large standard error (SE) (all ,0.06), and no
variable has a variance inflation factor (VIF) .1.30 (VIF
customarily should not exceed 10), indicating that the model does
not have a collinearity problem. Model discrimination, calibration,
and fit are summarized in Table S3. The p value of the goodness-
of-fit for the GLM was ,0.001 but the overfitting indices suggest
that there is not an issue with overfitting. The area under the ROC
curve was 0.72. The patient-level observed mortality rate ranges
from 2.7% in the lowest predicted decile to 35.6% in the highest
predicted decile, a range of 32.9%. The adjusted R
2 was 0.13.
Distribution of the standardized 30-day mortality rate is shown in
Figure 2. Using the complete 2000 dataset, the observed mortality
rate ranged from 0% to 100% across the 4,684 hospitals. The 25
th,
Claims Model for Mortality
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th, and 75
th percentiles for unadjusted mortality were 14.5%,
17.3%, and 20.7%, respectively. The distribution of RSMRs,
however, ranged from 13.0% to 23.7%, with 25
th,5 0
th, and 75
th
percentiles of 16.5%, 17.4%, and 18.3%, respectively.
Medical Record Validation
From a total of 75,616 cases for which administrative claims and
medical record abstracted data were available, the final medical
record derivation sample included 50,858 cases that met inclusion
criteria (Table S1). The unadjusted 30-day mortality rate for this
cohort was 14.5%. Twenty covariates based on the Pneumonia
PORT risk factors were included in the final model (Table S4).
The area under the ROC curve was 0.77 (Table S3). The
observed mortality rate ranged from 1.9% in the lowest predicted
decile to 45.9% in the highest. As expected, the explained
variation was higher in the medical record model (R
2=0.20) than
in the administrative model.
In this cohort of patients with medical record data, the
administrative model had an area under the ROC curve of
0.71, an observed mortality rate ranging from 2.4% in the lowest
decile to 36.9% in the highest predicted decile, and an adjusted R
2
of 0.12 (Table S3).
Estimated state-specific RSMRs derived from the medical
record and administrative models are displayed in Figure 3. The
slope of the weighted regression line of the state-specific RSMR
estimated from the 2 models is 0.77 (SE=0.06) with an intercept
of close to 0 (intercept=0.03; SE=0.01) and a correlation
coefficient of 0.86 (SE=0.03). The mean difference in RSMR
between the models is ,0.0001; the range was 20.0089 to 0.0088
so that both positive and negative differences were observed.
Stability of the Administrative Model over Time
The administrative model demonstrated good stability over
time. In each of the administrative validation cohorts, the model fit
was similar to the derivation cohort (Table S3). Unadjusted
mortality ranged from 14.0% in 2003 to 15.0% in the 2001
dataset. The percent explained variation ranged from 0.12 to 0.13,
while the area under the ROC curve was the same as in the
derivation sample (0.72).
Discussion
We have demonstrated that an administrative claims-based
model for calculating 30-day pneumonia mortality rates for
Medicare fee-for-service patients results in risk-standardized
estimates at the state level that are highly correlated with the
estimates obtained from a medical record model. For the purposes
of profiling outcomes, the claims model was a very good surrogate
for the medical record model, and the model was very stable over
time. Whileinsufficientsamplesofmedical recorddata preventedus
from validating our administrative claims model against medical
record data at the level of the individual hospital, the previously
developed risk-stratified measure of 30-day mortality for acute
myocardial infarction, which was developed using the same
methodology, was validated at the hospital level and demonstrated
similar findings from the administrative and medical record models
[11].Ourapproach to the developmentofthis administrativeclaims
model for profiling hospital mortality rates is consistent with the 7
preferred attributes identified in the American Heart Association
Scientific Statement that defined standards for statistical models
used for public reporting of health outcomes [13].
Several aspects of the development of this model warrant
additional discussion. We explicitly defined the population of
patients that are eligible for inclusion in the claims model and
chose the ICD-9-CM codes that are consistent with those used in
the National Pneumonia Project for patients with a principal
diagnosis of pneumonia [4]. We specifically did not include in the
sample those patients with a principal diagnosis of sepsis (038.xx)
or respiratory failure (518.81 or 518.84) with a secondary diagnosis
of pneumonia to avoid including cases where pneumonia could
have been a complication of the hospitalization. Although this is
not consistent with the denominator population of the National
Pneumonia Project, a medical record data element is used in the
Figure 2. Distribution of hospital-level standardized 30-day pneumonia mortality rates. Risk-standardized mortality rates for the 4,684
hospitals are based on the administrative claims model using data for 449,296 Medicare patients discharged during calendar year 2000.
doi:10.1371/journal.pone.0017401.g002
Claims Model for Mortality
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admission; this was not feasible based on claims. In addition, we
did not try to distinguish between community-acquired and
healthcare-associated pneumonia in our model, which is also
consistent with the denominator population of the National
Pneumonia Project, and consistent with the work of the
Pneumonia PORT and a number of studies linking processes of
care to patient mortality [14,20,22,23].
We chose 30 days after admission as the standard period for
outcome assessment. This approach is consistent with previously
National Quality Forum-endorsed mortality measures [11,12] and
the time frame of assessment used by the Pneumonia PORT, as well
as with prior studies of pneumonia processes and outcomes
[14,20,22,23]. Evaluating mortality at 30 days (as opposed to
evaluating in-hospital mortality) eliminates bias that might have
occurred due to varying lengths of inpatient stay, and removes any
incentive that might occur to discharge a patient from the hospital too
early. A period of outcomes evaluation that is longer than the usual
length of stay ensures that events early after discharge are captured,
and places a premium on appropriate discharge planning [9].
We employed hierarchical modeling in the development of this
model that accounts for clustering of patients within hospitals and
permits separation of within- and between-hospital variation in
observed outcomes. Use of hierarchical modeling reduces the
chance that a hospital will falsely be characterized as an ‘‘outlier’’
for pneumonia mortality. For hospitals with low patient volume,
predicted RSMRs will be at or near the national average.
For those patients who were transferred from one hospital to
another, we assigned responsibility for patient outcomes to the first
hospital. This approach increases accountability for the index
hospital to appropriately make decisions about transfer of patients,
and avoids hospitals that receive transfer patients who are seriously
ill from being inappropriately ‘‘penalized’’ for having higher
mortality rates [13]. Finally, all details of the development and
methodology used to generate this measure of hospital 30-day
mortality for pneumonia are in the public domain and subject to
ongoing critique and revision.
The coefficients in our model were consistent with clinical
expectations. Two exceptions were chronic obstructive pulmonary
disease (HCC 108) and asthma (HCC 110), which among those
patients with pneumonia were prognostically favorable. However,
these results are consistent with what was found in the Pneumonia
PORT.On an empirical basis,thisappearsto be a true relationship.
The underlying mechanism is unknown, but it may be related to
unmeasured factors related to pneumonia severity in these patients.
There are several issues to consider about our methodology.
The model is specific to Medicare fee-for-service patients and may
not be generalizable to other data sources and patient populations.
However, while the model was limited to Medicare patients,
approximately two-thirds of all hospitalizations for pneumonia
occur in this age group. Additionally, the only national data
available on which to calculate the RSMRs are Medicare claims.
The need to evaluate paid hospital claims and all claims from the
year before the index hospitalization results in significant time lags
between patient care and reported measure rates. Consistent with
measure criteria from the National Quality Forum, the mortality
model does not adjust for socioeconomic status, race, or ethnicity
because risk-adjusting for socioeconomic status would hold
hospitals with a large proportion of such patients to a different
standard of care than hospitals treating a larger proportion of
patients of higher socioeconomic status [24]. An additional issue is
whether an area under the ROC curve of 0.70 for discriminating
survivors from non-survivors is good enough to publicly report
hospital mortality. The goal of the model is to produce estimates of
hospital performance. The estimates from this model agree
strongly with the estimates from a medical record model with a
higher C-statistic. Moreover, interval estimates of RSMRs can be
obtained using the bootstrap resampling method [25,26]. We
believe that much of the unexplained variation in the RSMR
derives from the latent variable of hospital quality. Finally,
Figure 3. Comparison of the state-level risk-standardized mortality rates generated by the medical record model and the
administrative model. Risk-standardized mortality rates were generated with both models for the 50,858 patients in the chart model derivation
cohort. The correlation coefficient for rates generated by the 2 models is 0.86 (Standard Error=0.032).
doi:10.1371/journal.pone.0017401.g003
Claims Model for Mortality
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pneumonia coding by hospitals [27,28].
We developed an administrative claims-based model for
profiling hospitals for pneumonia mortality that is a good proxy
for results from a medical record model. Despite limitations of
currently available data, this model represents a valuable tool in
assessing the outcomes achieved by states and hospitals in caring
for patients with pneumonia, and has been endorsed by the
National Quality Forum as a measure for acute care hospital
performance [29]. Since initial development, several minor
changes have been made to the model including expanding the
cohort to include patients with viral pneumonia (adenovirus
[480.0], respiratory syncytial virus [480.1], and parainfluenza
virus [480.2]), and excluding patients who had enrolled in the
Medicare hospice benefit before hospitalization (,1% of patients
with pneumonia) [30]. CMS first began using the model for public
reporting in August 2008 and hospital-specific findings are now
reported on Hospital Compare [31].
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